Bio Green Med Solution, Inc. Common Stock
Symbol: BGMS (NASDAQ)
4.91
▲ (4.09%) 0.193
Company Description:
Bio Green Med Solution Inc is a clinical-stage biopharmaceutical company that develops targeted medicines for cancer and other proliferative diseases. The company develops several families of anticancer drugs that act on the cell cycle, including CDK (cyclin-dependent kinase) inhibitors and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include fadraciclib and plogosertib. The company derives its revenue from United Kingdoms.
Key Stats
- Today's Open: $5.18
- Today's High: $7.661
- Today's Low: $4.326
- Today's Volume: 4.55M
- Yesterday Close: $4.72
- Yesterday High: $4.7624
- Yesterday Low: $4.31
- Yesterday Volume: 2.94M
- Last Min Volume: 6.82K
- Last Min High: $4.945
- Last Min Low: $4.915
- Last Min VWAP: $4.93681
Company Profile
- Name: Bio Green Med Solution, Inc. Common Stock
- Website: https://cyclacel.com
- Listed Date: 2006-03-28
- Location: BERKELEY HEIGHTS, NJ
- Market Status: Active
- CIK Number: 0001130166
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $13.87M
- Round Lot: 100
- Outstanding Shares: 2.94M
- Asset Type: CS
RECENT FILINGS FOR BGMS
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-10-07 | 8-K | View |
| 2025-10-07 | 8-K | View |
| 2025-09-25 | 8-K | View |
| 2025-09-17 | 8-K/A | View |
| 2025-09-17 | 424B3 | View |
| 2025-09-16 | 8-K | View |
| 2025-09-16 | SCHEDULE 13G | View |
| 2025-09-16 | 3 | View |
| 2025-09-12 | 425 | View |
| 2025-09-12 | 8-K | View |
| 2025-09-11 | EFFECT | View |
| 2025-09-10 | 4 | View |
| 2025-09-05 | 425 | View |
| 2025-09-05 | 8-K | View |
| 2025-09-04 | 8-K | View |
| 2025-09-04 | 4 | View |
| 2025-09-04 | 4 | View |
| 2025-09-04 | 4 | View |
| 2025-09-02 | POS AM | View |
| 2025-09-02 | SCHEDULE 13G/A | View |